NorthStar Asset Management (Massachusetts)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$264K Sell
1,049
-60
-5% -$12.9K 0.08% 79
2026
Q1
$241K Hold
1,109
0.07% 79
2025
Q4
$253K Sell
1,109
-9
-0.8% -$2.05K 0.07% 77
2025
Q3
$259K Buy
+1,118
New +$228K 0.07% 66

Other funds holding ABBV

NorthStar Asset Management (Massachusetts)'s ABBV Position: Q2 2026 in Review

NorthStar Asset Management (Massachusetts) reduced its AbbVie (ABBV) stake by 5.4% in Q2 2026, selling an estimated $12.9K and leaving 1,049 shares worth $264K. The position accounts for 0.08% of the portfolio, ranked #79.

NorthStar Asset Management (Massachusetts) first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • NorthStar Asset Management (Massachusetts) held 1,049 shares of AbbVie worth $264K as of Q2 2026.
  • NorthStar Asset Management (Massachusetts) sold 60 AbbVie shares in Q2 2026, an estimated $12.9K.
  • AbbVie made up 0.08% of NorthStar Asset Management (Massachusetts)'s portfolio in Q2 2026, its #79 holding.
  • NorthStar Asset Management (Massachusetts) first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on NorthStar Asset Management (Massachusetts)'s 13F filing for Q2 2026, filed 28 Jul 2026.